ResMed, Inc. (NYSE:RMD)
CAPS Rating:
The Company is a developer, manufacturer and distributor of medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders.
The Company is a developer, manufacturer and distributor of medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders.
Recs
this company has a unique product, with little to no competition in it's industry, it possesses a book value of $175 per share, and is trading way below that value and it's intrinsic value. Not to mention the company has a great balance sheet and income statement. This is a golden chicken egg just waiting to hatch.